INOVIO Receives FDA Accelerated Approval for VOCERYQINOVIO (NASDAQ: INO) has received accelerated approval from the U.S. Food and Drug Administration (FDA) for VOCERYQ, a DNA-based immunotherapy designed to reduce the frequency of surgery in adults with recurrent respiratory papillomatosis (RRP), a rare disease associated with human papillomavirus (HPV) infection.
The treatment, previously known as INO-3107, targets HPV-6 and HPV-11 and is described by the company as the first DNA medicine approved by the FDA. INOVIO expects VOCERYQ to become av
INTC ▼ SHORT · Guide cut, -25% · 69 / 74 / 77 → 64 / 60▸ WHY: Q4 guide came in at $15-16B vs $17.1B street, and they say the PC slump runs into H1 2027. capex next year way higher on top of that. BofA and Roth both cut to Neutral this morning. -25% premarket, way more than options priced in, so I think sellers are still getting out
▸ LEVELS: 92.07 yesterday's close · 81.79 Jul 29 low, broken overnight · 74-77 after-hours bounce zone · 66.85 premarket low
▸ PLAN: scaling in, three pieces
- tier 1: short here, ~69 premarket
- tier 2: add at 74 if a
Swing Trade Idea | $BA Short | 2:1 P&L NYSE:BA Looks very weak for the long-term and swing trading opportunity on the way.
If it can close below the $173.5 marking today and goes below the Short Entry level at $170.00 then i would be looking to go short and keep the target to 162.00 and final target to the $155 level.
Wouldn't be surprised to see the big tech NASDAQ:QQQ go up for the a few days. So this trade may take some time to fully play out since NYSE:BA has been going slow for the weeks.
Broadcom (AVGO) Stock: Market CommentaryBroadcom (NASDAQ: AVGO) is approaching an important support area after several months of downward pressure.
The $320 level is now the key area to watch. It marks Broadcom's lowest price in the past six months and sits close to the lower boundary of its descending price structure. This makes the zone important for buyers who may be looking for an opportunity to step in. The stock has already experienced several sharp declines from previous resistance levels, including $432.49 and $380.84
Howev
GPRO Long Trendline break + retest, weekly SMA50 as support
Entry 1.29
Stop 0.97
Target 2.5, 3.8, 6
Risk management is much more important than a good entry point.
I am not a PRO trader. About 25% of my trades had been stopped quickly.
buy 200 shares.
1.29 x 200
If stopped at 0.97, stop loss about 0.32x 200
BETR - Expands Northeast Florida Presence with $140 MillionBetter Home & Finance announced that it has expanded its Northeast Florida presence by adding a purchase-focused mortgage team with $140 million in associated volume through its NEO Home Loans channel. The move highlights Better’s continued effort to grow its purchase-mortgage capabilities and bring its technology-driven lending approach to more borrowers and loan professionals.
About Better
Better Home & Finance Holding Company (NASDAQ: BETR) describes itself as the first AI-native mortgage a
DFDV LongBreakout resistance + retest + higher high
Entry 6
Stop 4
Target 13, 28
Risk management is much more important than a good entry point.
I am not a PRO trader. About 25% of my trades had been stopped quickly.
BFF (buy for Free)
SellToOpen 2028-1-21 P2.5, 0.7 x2 (Delta=-0.09)
BuyToOpen 2028-1-21 C7.5/20, 1.5 (C7.5 Delta= 0.7)
Total cost 0.1
If this option plan is stopped at 4.0, stop loss about 1.0
CSCO Stock: Market CommentaryCisco Systems (NASDAQ: CSCO) remains under selling pressure, with shares falling 1.13% to close at $103.33 on Monday. The latest decline has pushed the stock below the $104.51 support level, raising concerns that sellers may be gaining further control.
The daily chart shows a clear downward trend. The break below $104.51 is worth watching. This level had provided support during previous declines, but the latest daily close below it puts buyers in a difficult position. If the stock fails to recl
VALE LongTrendline break + retest, Near daily support
Entry 14.5
Stop 12.5
Target 18, 21
Risk management is much more important than a good entry point.
I am not a PRO trader. About 25% of my trades had been stopped quickly.
BFF (buy for Free)
SellToOpen 2027-1-15 P13, 0.51 (Delta=-0.25)
BuyToOpen 2027-1-15 C16, 0.59 (Delta= 0.35)
Total cost 0.08
If this option plan is stopped at 12.5, stop loss under 2.
If price up to 18, C16 $2. Reward:risk=2:2 = 1:1
If price up to 21, C1
IREN LongDemand Zone
Entry 28
Stop 24
Target 73
Risk management is much more important than a good entry point.
I am not a PRO trader. About 25% of my trades had been stopped quickly.
BFF (buy for Free)
SellToOpen 2027-6-17 P15, 1.99 (Delta=-0.11)
BuyToOpen 2027-6-17 C50/80, 2.04 (C50 Delta= 0.36)
Total cost 0.05, near "0"
PCAL Nears a Projected Reversal Zone After Channel BreakdownPCAL Nears a Projected Reversal Zone After Channel Breakdown
PCAL remains bearish on the daily chart after breaking below its rising channe l. Price has continued making lower highs and lower lows, with the latest candle closing near 120.80.
Potential Reversal Area: Projecting the previous supply move highlights 108–114 as a possible reversal zone. Price is approaching this area, but a bullish reversal has not yet been confirmed.
Bullish Confirmation: I’m watching for a bullish engulfi
FFC Breaks Above Triangle: Reversal Zone Near 580 in FocusFFC Breaks Above Triangle: Reversal Zone Near 580 in Focus
FFC has broken above its triangle structure on the 4-hour chart, advancing from the 530–537 area toward 564.70. The breakout supports short-term bullish momentum, while an important resistance zone remains overhead.
Potential Reversal Area: Projecting the previous demand move highlights 577–582 as a possible bearish reversal zone. This area also aligns with the previously broken rising trendline, creating potential support-to-res
TSLA 2023 vs. 2026: Breakout or Fake-out?TSLA is respecting the same algorithms we saw in 2023 and telling a very similar story.
Here’s the side-by-side: and my plan to confirm the breakout, rejection, or invalidation.
Liquidity build (high to low)
2023: ~$414 to $101.81, -75% over ~61 weeks
Now: $498.83 to ~$298, -40% over ~31 weeks
Bottom to break of the black
2023: +138% in ~22 weeks
Now: +36% in ~14 weeks
The bounce is faster and stronger this time.
The key difference
In 2023, price respected a tapered, weaker buying
Oracle Stock: Market CommentaryOracle (NYSE: ORCL) shares fell 6.29% on Monday, closing at $122.45. The drop brings the stock back to a key support area, while investors remain concerned about how the company will pay for its growing AI ambitions and the rising cost of its expansion.
Oracle's heavy spending on AI infrastructure is starting to raise questions among investors. The company plans to raise around $20 billion through a mix of debt and share offerings to help fund its expansion. Much of that money will go toward bu
SPCX 1D: Can SpaceX Stock Recover From the Recent Sell-Off?SPCX is still trading inside a descending channel after getting rejected near $175 in October. The recent bounce from the lower channel boundary has brought price back to the $140–143 supply zone. This is the area I'm interested in for a possible short entry.
The recovery looks more like a retest of resistance than a confirmed trend reversal. Price needs to break the descending structure and hold above supply before I consider a bullish shift.
Why SPCX Is Worth Following
The potential Tesla–S
SNAP: 87% Call Flow Off the 200-Day Into Nov 4 EarningsSNAP is bouncing off its 200-day SMA two days before earnings, and 87% of today's options premium is in calls.
OPTIONS FLOW (Nov 2, GTA Wire, 12:40 PM ET)
- $1.6M premium: $1.4M calls, $197K puts (87% calls)
- Put/call volume ratio 0.19
DARK POOLS (off-exchange share)
Oct 26: 37.7% | Oct 27: 44.4% | Oct 28: 50.0% | Oct 29: 40.7% | Oct 30: 46.5%
TECHNICALS (Daily)
- Price near 5.56, back above the 200-day (5.43) and 100-day (5.32) SMAs, still under the 50-day (5.76) and 20-day (6.10)
- Four st
P: 67% Put Premium as Everpure Drops 8% Under the 50-DayEverpure is down about 8% today and trading under its 50-day SMA, with two-thirds of the options premium in puts.
OPTIONS FLOW (Nov 2, GTA Wire, 12:40 PM ET)
- $4.2M premium: $1.4M calls, $2.8M puts (33% calls / 67% puts), put/call volume 1.5
- Dec 18 $135 puts: 326 contracts vs 151 OI, about $740K
- Nov 20 $100 puts: 753 vs 406 OI, about $270K
- Dec 18 $150 calls: 384 vs 26 OI, about $162K
DARK POOLS (off-exchange share)
Oct 26: 38.5% | Oct 27: 41.4% | Oct 28: 33.5% | Oct 29: 42.3% | Oct 30:
AI | My Biggest Bet Right Now. This is my biggest bet at the moment. That earns it the closest scrutiny in my book.
On this 4H chart, C3.ai trades around $11.92, consolidating after a volatile October advance and pullback. The rising channel structures frame a potential recovery, with highlighted demand beneath price and supply near the recent swing high.
I’m backing the recovery scenario. Price still has to deliver the evidence.
The immediate assignment — defend demand
The nearest orange box marks the consolidation area I
Starbucks Corporation (NASDAQ: SBUX) – Daily Timeframe.Entry Zone: around $98.50
Short-Term Target: $109.25 – $109.65
Short-Term Stop Loss: $93.45
📈 Bullish Scenario:
If price holds above $98.50, the stock may move toward $109.
📉 Bearish Scenario:
If $98.50 breaks, price could drop toward $93 – $90.
🎯 Long-Term Target: $139.50.
$ORCL | Major Weekly Support, Is a Recovery Taking Shape?WEEKLY STRUCTURE
Oracle has experienced a significant correction over the past few months, falling from highs at $340 to its current price around $122.
The stock is now trading at a major weekly support zone, an area that has repeatedly attracted buyers since 2023.
What makes this level particularly interesting is its history. It previously acted as resistance before becoming an important support area, with several strong rallies originating from this region.
THE FUNDAMENTAL PICTURE
Orac
PALANTIR Closed below the 1D MA50 after 3 months. $160 possible.Palantir (PLTR) closed on Friday below its 1D MA50 (blue trend-line) for the first time in 3 months. This has confirmed the short-term trend shift from bullish to bearish.
Even structurally, the pattern of these past 3 months resembles the price action of August - October last year (2025). Once the stock closed below its 1D MA50 on November 06 2025, it extended the decline to a total -29% drop. In fact all declines in the past 1.5 year have been around that level.
As a result, we expect Palant























